publication venue for
- Specificity and functional humoral immune responses induced by the VBI-1501A eVLP HCMV gB vaccine compared to the gB/MF59 vaccine.. 21. 2025
- Broadening sarbecovirus neutralization with bispecific antibodies combining distinct conserved targets on the receptor binding domain.. 20. 2024
- The co-presence of high-risk human papillomaviruses and Epstein-Barr virus is linked with tumor grade and stage in Qatari women with breast cancer.. 17. 2020
- Tumor mutational burden as a predictive biomarker for checkpoint inhibitor immunotherapy.. 16. 2019
- Preclinical development of HIvax: Human survivin highly immunogenic vaccines.. 11. 2015
- Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany. 2021
- Epstein-Barr virus (EBV) status in colorectal cancer: a mini review. 2018
- Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma. 2023
- Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United States. 2022
- Evidence and speculations: vaccines and therapeutic options for COVID-19 pandemic. 2020
- Duality at the gate: Skin dendritic cells as mediators of vaccine immunity and tolerance. 2016